Salesforce Raises FY2027 EPS 7% and Launches $25B Buyback — What Leveraged CRM CFD Traders Must Know

Published:

Data Snapshot

Price
$177.89
24h Low
$176.95
24h High
$183.91
ASR Size
$25B
CRM Price
$177.89
24h Change
-0.78%
24h Change (%)
-0.78%
FY27 Revenue Guide
$45.9B–$46.2B
FY27 Adj. EPS Guide
$14.06–$14.12

Key Takeaways

  • FY2027 adjusted EPS raised ~7% to $14.06–$14.12, a materially stronger profitability signal than the marginal revenue guidance lift alone.
  • The $25B ASR front-loads net buying pressure via bank hedging flows — a structural tailwind for CRM during the repurchase window.
  • At 50x leverage on CoinUnited, a 2% CRM move (~$3.56) equals a full margin gain or loss — liquidation sits near the 24h low of $176.95.
  • Enterprise SaaS peers (Microsoft, Alphabet, Meta) receive an indirect sentiment boost as Salesforce signals healthy FY27 IT demand.
  • Guidance is only marginally above Street consensus (~$46.1B); a 'sell-the-news' flush to $176.95 support is a credible short-term risk.
The chart illustrates the performance of Salesforce, Inc. (CRM) over the last 24 hours. The stock opened at $180.145 and closed at $177.855, marking a decline of 1.27%. The highest price reached during this period was $183.90, while the lowest was $176.965. In comparison, the related indices show the US100 down by 0.39% and the US500 down by 0.07%. This indicates that while Salesforce experienced a notable drop, the broader market indices also faced slight declines, suggesting a correlated market movement. Leveraged traders should note these figures when considering their positions in CRM CFDs, especially in light of the recent announcement of a $25 billion buyback and a 7% increase in FY2027 EPS guidance.
Salesforce (CRM) closed at $177.855, down 1.27% in the last 24 hours.

According to StockAnalysis, Salesforce, Inc. (CRM) has raised its FY2027 adjusted EPS guidance to $14.06–$14.12 from $13.11–$13.19 — a roughly 7% step-up — while narrowing revenue guidance to $45.9B–$

Event Summary

According to StockAnalysis, Salesforce, Inc. (CRM) has raised its FY2027 adjusted EPS guidance to $14.06–$14.12 from $13.11–$13.19 — a roughly 7% step-up — while narrowing revenue guidance to $45.9B–$46.2B (from $45.8B–$46.2B prior). Simultaneously, Salesforce announced a $25 billion accelerated share repurchase (ASR), one of the largest in enterprise software history, signaling high management confidence in sustained free cash flow generation.

The ASR follows a broader shift in Salesforce's capital allocation strategy — from growth-at-all-costs SaaS toward a mature, cash-returning platform business, partly driven by activist shareholder pressure. Despite the bullish guidance, CRM is trading at $177.89, down 0.78% on the day (24h high: $183.91), suggesting the market is awaiting confirmation. As detailed in our guide on earnings beat sector playbooks, post-announcement consolidation near lows is a common setup before the re-rating move materializes.

Leverage Impact Analysis

With CRM currently at $177.89, leveraged CFD traders face a compressed risk window. CoinUnited.io offers up to 2000x leverage on stock CFDs, so position sizing is critical here.

Worked example — Long CRM CFD at 50x leverage:

  • -Entry: $177.89 | Notional: $177.89 per unit
  • -A 2% move to ~$181.45 (toward the 24h high of $183.91) generates a 100% return on margin
  • -Liquidation zone: A ~2% adverse move (~$174.09) wipes the position at 50x
  • -The $183.91 recent high acts as the immediate resistance/liquidation reference for short sellers

ASR mechanics matter for leverage traders: The $25B ASR front-loads net buying pressure as counterparty banks hedge by purchasing CRM shares in the open market. This creates a structural bid that can absorb selling pressure — reducing downside velocity during the ASR window but not eliminating gap risk on macro shocks.

Key risk: Guidance is only marginally above Street consensus (~$46.1B revenue). If the market has already priced the beat, a "sell-the-news" flush toward the 24h low of $176.95 is plausible. Traders running >100x leverage should be aware that a 1% dip from current levels reaches that threshold rapidly.

Cross-Market Impact

This event is primarily CRM-specific but carries read-throughs worth monitoring:

  • -NASDAQ 100 Index & S&P 500 Index: CRM is a meaningful index constituent. A sustained re-rating could provide marginal index uplift, particularly for tech-weighted ETFs. However, the impact is secondary to macro rate signals.
  • -Sector rotation: Salesforce's pivot to buybacks and margin expansion sets a benchmark for mature SaaS. This supports the equity offering and capital markets surge narrative — investors may rotate toward software names with credible FCF-return stories and away from pure-growth names without buyback programs.
  • -Commodities/Forex: Minimal direct linkage. This is a corporate-specific event with limited macro spillover to gold, oil, or DXY.

Trading Considerations

Key levels to monitor: $183.91 (24h high / near-term resistance), $176.95 (24h low / immediate support), and the psychological $180 level as a pivot. Volume confirmation on any break above $183.91 would strengthen the bull case for a re-rating toward prior highs.

The primary risk factor is consensus proximity — with Street revenue consensus near $46.1B and guidance topping at $46.2B, the upside surprise is modest. Traders should watch whether forward P/E compression or expansion follows EPS guidance revisions. For context on how earnings beats translate to sustained price action, the EPS re-rating is typically the more durable driver versus marginal revenue beats.

Trade Salesforce, Inc. on CoinUnited.io

Trade CRM with up to 800xx leverage → | Create Free Account

Frequently Asked Questions

The ASR creates a structural bid as counterparty banks purchase CRM shares to hedge their exposure, reducing downside velocity during the repurchase window. However, this doesn't eliminate gap risk — leveraged longs above 50x still face liquidation on any ~2% adverse move from the $177.89 entry level.

Disclaimer: This brief is for educational purposes only and is not investment advice.